-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, Kangchen Pharmaceutical's Phase III clinical trial of Class 1.
2 innovative herb tablets completed the enrollment of the first subject
.
According to data from Minai.
com, the sales of gynecological proprietary Chinese medicine in China's urban physical pharmacies in 2022E are close to 4.
7 billion yuan, and gynecological menstrual adjustment drugs and gynecological inflammatory drugs are the main forces; Among the TOP20 products, 11 exclusive varieties are on the list; Among the top 20 brands, Dingkundan, Jieryin lotion and Xiaoyao pills ranked in the top three, and the sales of fragrant peony granules and Kangnu gel rose by 127.
16% and 21.
26%
respectively.
There are 16 new gynecological traditional Chinese medicine drugs under research, and Kangyuan Pharmaceutical occupies 4 models
.
2 innovative herb tablets completed the enrollment of the first subject
.
According to data from Minai.
com, the sales of gynecological proprietary Chinese medicine in China's urban physical pharmacies in 2022E are close to 4.
7 billion yuan, and gynecological menstrual adjustment drugs and gynecological inflammatory drugs are the main forces; Among the TOP20 products, 11 exclusive varieties are on the list; Among the top 20 brands, Dingkundan, Jieryin lotion and Xiaoyao pills ranked in the top three, and the sales of fragrant peony granules and Kangnu gel rose by 127.
16% and 21.
26%
respectively.
There are 16 new gynecological traditional Chinese medicine drugs under research, and Kangyuan Pharmaceutical occupies 4 models
.
The 5 billion gynecological proprietary Chinese medicine market of physical pharmacies, led by Qianjin, Guangyuyuan and Enwei
According to the latest data from Minai.
com, in recent years, the terminal sales scale of gynecological proprietary Chinese medicines in China's urban physical pharmacies has continued to remain above 5 billion yuan, but it is expected that the sales scale will be close to 4.
7 billion yuan in 2022, down 7.
05%
year-on-year.
com, in recent years, the terminal sales scale of gynecological proprietary Chinese medicines in China's urban physical pharmacies has continued to remain above 5 billion yuan, but it is expected that the sales scale will be close to 4.
7 billion yuan in 2022, down 7.
05%
year-on-year.
Sales of gynecological proprietary Chinese medicines in Chinese urban physical pharmacies (: 10,000 yuan)
Source: Competition pattern of drug terminals in China's urban physical pharmacies
From the perspective of manufacturer pattern, the TOP5 manufacturers are Zhuzhou Qianjin Pharmaceutical, Shanxi Guangyuyuan, Sichuan Enwei Pharmaceutical, Zhongjing Wanxi Pharmaceutical, and Jiuzhitang
.
Qianjin Pharmaceutical first topped the list in 2021 and is expected to continue to top the list in 2022; Sichuan Enwei Pharmaceutical's market share has steadily increased in recent years, and it has squeezed into the top three
for the first time.
.
Qianjin Pharmaceutical first topped the list in 2021 and is expected to continue to top the list in 2022; Sichuan Enwei Pharmaceutical's market share has steadily increased in recent years, and it has squeezed into the top three
for the first time.
From the perspective of the subdivision of gynecological proprietary Chinese medicines, the total market share of the two main forces of gynecological menstrual medicine and gynecological inflammatory drug exceeded 80%, of which the market share of gynecological menstrual medicine was close to 44%, which continued to lead the market; The market share of gynecological inflammatory drugs exceeded 39%, ranking second
.
.
2022E Subcategory pattern of gynecological proprietary Chinese medicine in China's urban physical pharmacies
Source: Competition pattern of drug terminals in China's urban physical pharmacies
Gynecological Chinese proprietary medicine TOP20! 11 exclusive varieties on the list, Yangtze River soared 127%
Among the top 20 gynecological proprietary Chinese medicine products, 12 products are expected to have sales of more than 100 million yuan, and Xiaoyao Pill, Dingkundan and Jieryin Lotion rank in the top three, with sales exceeding 200 million yuan
.
.
2022E Top 20 gynecological proprietary Chinese medicine products in Chinese urban physical pharmacies
Source: Competition pattern of drug terminals in China's urban physical pharmacies
From the perspective of subdivided categories, 20 products are mainly concentrated in gynecological menstrual adjustment drugs and gynecological inflammatory drugs, with 9 products on the list, and gynecological fetal drugs and women's menopausal drugs each have one product on the list
.
.
The 11 products are exclusive varieties, including Sichuan Enwei Pharmaceutical's Jie'er Yin Lotion, Hainan Bikai Pharmaceutical's Bao's Bao's Mother's Suppository, Zhuzhou Qianjin Pharmaceutical's Gynecological Tablets and Gynecological Qianjin Capsules, Guiyang Xintian Pharmaceutical's Kuntai Capsules and Radix Gel, Beijing Tongrentang's Tongren Wuji Baifeng Pills, Buchang Pharmaceutical's Red Core Women's Cleansing Lotion, Baiyunshan Zhongyi Pharmaceutical's Kidney Nourishing Pills, Yangtze River Pharmaceutical's Xiangpeony Granules, and Guizhou Jianxing Pharmaceutical's Kangnu Gel
.
.
Among the top 20 gynecological proprietary Chinese medicine brands, Dingkundan from Shanxi Province has been ranked first for many consecutive years, Sichuan Enwei Pharmaceutical's Jieryin Lotion has been ranked second since 2019, and Zhongjing Wanxi Pharmaceutical's Xiaoyao Pill has ranked third
for the first time.
Zhuzhou Qianjin Pharmaceutical, Guiyang Xintian Pharmaceutical, Buchang Pharmaceutical and other 3 enterprises each have 2 brands on the list
.
for the first time.
Zhuzhou Qianjin Pharmaceutical, Guiyang Xintian Pharmaceutical, Buchang Pharmaceutical and other 3 enterprises each have 2 brands on the list
.
2022E China Urban Brick-and-mortar Pharmacy Gynecology Chinese Proprietary Medicine Brand TOP20
Source: Competition pattern of drug terminals in China's urban physical pharmacies
From the perspective of sales changes, Yangzijiang Pharmaceutical's peony granules and Guizhou Jianxing Pharmaceutical's Kangwu gel performed well, increasing by 127.
16% and 21.
26%
respectively.
It is worth mentioning that these two brands are among the TOP20 for the first time, ranking 15th and 17th respectively
.
16% and 21.
26%
respectively.
It is worth mentioning that these two brands are among the TOP20 for the first time, ranking 15th and 17th respectively
.
16 new gynecological Chinese medicine drugs under research! Kang Chen, Kang Yuan, Tasly.
.
.
Force
.
.
Force
According to data from Minai.
com, in 2021, the sales scale of gynecological proprietary Chinese medicine in China's three major terminal markets (see the end of this article for statistical scope) exceeded 19 billion yuan
.
As a disease that seriously threatens women's health, gynecological diseases have received more and more attention, and the research and development of new gynecological traditional Chinese medicine drugs continues to advance
.
com, in 2021, the sales scale of gynecological proprietary Chinese medicine in China's three major terminal markets (see the end of this article for statistical scope) exceeded 19 billion yuan
.
As a disease that seriously threatens women's health, gynecological diseases have received more and more attention, and the research and development of new gynecological traditional Chinese medicine drugs continues to advance
.
On November 8, Kangchen Pharmaceutical issued an announcement that the company is currently carrying out the phase III clinical trial of traditional Chinese medicine 1.
2 innovative medicine Golden Herb tablets, and has recently completed the enrollment of the first subject
.
Golden Grass Tablets is an effective part preparation, which is extracted and refined by modern technology of the Chinese herbal medicine "Muscles and Bones", which is different from the Chinese medicine compound preparation, and has the characteristics of
clear composition and controllable quality.
At present, there is no effective part preparation
of Chinese medicine that has been marketed in China for the treatment of "pelvic inflammatory disease sequelae chronic pelvic pain" indication.
2 innovative medicine Golden Herb tablets, and has recently completed the enrollment of the first subject
.
Golden Grass Tablets is an effective part preparation, which is extracted and refined by modern technology of the Chinese herbal medicine "Muscles and Bones", which is different from the Chinese medicine compound preparation, and has the characteristics of
clear composition and controllable quality.
At present, there is no effective part preparation
of Chinese medicine that has been marketed in China for the treatment of "pelvic inflammatory disease sequelae chronic pelvic pain" indication.
In the field of gynecological diseases, there are currently 16 new gynecological traditional Chinese medicine drugs in China that are in the clinical approval stage or above, involving Kangchen Pharmaceutical, Kangyuan Pharmaceutical, Tasly, Shanghai Cai Tongdetang, Baiyunshan Zhongyi Pharmaceutical, Sanyi Biotechnology, Jiangxi Baishen Changnuo Pharmaceutical and other enterprises
.
.
Among the 16 new gynecological traditional Chinese medicine drugs, Kangchen Pharmaceutical's Golden Herb Tablets, Kangyuan Pharmaceutical's Ginsengpu Potitis Granules and Liuwei Rehmanin Sugar Tablets were all in phase III.
clinical stage.
8 new drugs are in the phase II clinical stage, including Kangyuan Pharmaceutical's Qibi Lubao Granules and Zhenggong Capsules, Tasly's Qi Ling Wen Kidney Capsule Capsule Granules, Shanghai Cai Tongdetang's Flavored Unexhausted Tablets, Baiyunshan Zhongyi Pharmaceutical's Kidney Nourishing Pills.
.
.
clinical stage.
8 new drugs are in the phase II clinical stage, including Kangyuan Pharmaceutical's Qibi Lubao Granules and Zhenggong Capsules, Tasly's Qi Ling Wen Kidney Capsule Capsule Granules, Shanghai Cai Tongdetang's Flavored Unexhausted Tablets, Baiyunshan Zhongyi Pharmaceutical's Kidney Nourishing Pills.
.
.
Gynecological proprietary Chinese medicines are mainly new drugs under development
Source: Minai.
com China Drug Clinical Trial Publicity Database
com China Drug Clinical Trial Publicity Database
Kangyuan Pharmaceutical is a leading enterprise in domestic traditional Chinese medicine innovation, and gynecological disease medicine is one of the company's main product lines, and has listed as many as 15 varieties
of gynecological proprietary Chinese medicine.
At present, the company is researching new gynecological drugs, including ginseng pobenitis granules, six flavor rehmanin sugar tablets, zhenggong capsules, seven-digit decept granules, etc.
, which have been in the phase III or phase II clinical stage, and are expected to usher in the harvest period
one after another.
of gynecological proprietary Chinese medicine.
At present, the company is researching new gynecological drugs, including ginseng pobenitis granules, six flavor rehmanin sugar tablets, zhenggong capsules, seven-digit decept granules, etc.
, which have been in the phase III or phase II clinical stage, and are expected to usher in the harvest period
one after another.
As a leading enterprise in the internationalization of modern Chinese medicine, Tasly has also laid out in the field of gynecological diseases, the company has 10 gynecological proprietary Chinese medicines approved for marketing, the company's Kunxinning granules are the first approved class 1.
1 gynecological traditional Chinese medicine innovative drugs in China, and Qiling Wen kidney capsule granules for the treatment of polycystic ovary syndrome are in the phase II.
clinical stage
.
1 gynecological traditional Chinese medicine innovative drugs in China, and Qiling Wen kidney capsule granules for the treatment of polycystic ovary syndrome are in the phase II.
clinical stage
.
Data source: Minainet database, company announcement note: Minai.
com "China's three major terminals and 6 major market competition patterns", the statistical scope is: urban public hospitals and county-level public hospitals, urban community centers and township health centers, urban physical pharmacies and online pharmacies, excluding private hospitals, private clinics, village clinics, excluding county and rural pharmacies; Minai.
com "Drug Terminal Competition Pattern of China's Urban Physical Pharmacies", the statistical scope is: physical pharmacies in cities at the prefecture level and above nationwide, excluding county and rural pharmacies; All sales are based on the average retail price of the product
.
com "China's three major terminals and 6 major market competition patterns", the statistical scope is: urban public hospitals and county-level public hospitals, urban community centers and township health centers, urban physical pharmacies and online pharmacies, excluding private hospitals, private clinics, village clinics, excluding county and rural pharmacies; Minai.
com "Drug Terminal Competition Pattern of China's Urban Physical Pharmacies", the statistical scope is: physical pharmacies in cities at the prefecture level and above nationwide, excluding county and rural pharmacies; All sales are based on the average retail price of the product
.
